We have developed a unique portfolio of products and services, including user-friendly nicotine delivery systems and patient-facing, unique smoking cessation counselling and support facilities.

Our diverse range incorporates leading-edge delivery devices, the manufacture of world-class nicotine preparations, bespoke online mentoring support services, and systems built to capture qualitative data, enabling further product and service improvement decisions to be made from sound foundations.

The ability to provide such diverse solutions clearly demonstrates CNC’s commitment to interact with smokers on every level; the only way we believe it is possible to make a significant difference is by enhancing the efficacy of cessation programmes currently available and addressing the massive issues created by smoking.


Date Type Amount Investors Valuation
01/01/12 Series A 3.1M Advent Life Sciences Unknown